相关实验视频

Updated: Jan 9, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

针对E3结合酶RFFL的反感性寡核酸增强了CFTR调节器在CF初级支气管上皮细胞中的有效性

Daichi Hinata¹, Yukari Kai¹, Ryosuke Fukuda¹

¹Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Hyogo 669-1330, Japan.

Molecular therapy. Nucleic acids

|December 1, 2025

概括

新的反感性寡核酸 (ASOs) 准RFFL以稳定CFTR蛋白. 这种方法增强了目前的囊性纤维化 (CF) 疗法,并为罕见的CFTR突变提供了潜在的可能性.

科学领域:

生物化学生化学
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

囊性纤维化 (CF) 主要是由CFTR基因的ΔF508突变引起的,导致蛋白质错误折叠和降解.
目前的CFTR调节剂,如elexacaftor/tezacaftor/ivacaftor (ETI),显示出临床益处,但对罕见或不响应的CFTR突变的疗效有限.
RFFL是一种E3泛基因酶,调节CFTR的血表达,影响调节器的有效性.

研究的目的:

开发新的反感性寡核酸 (ASOs) 来选择性地抑制RFFL表达.
评估针对RFFL的ASO提高CFTR调节器功效的潜力,特别是挑战CFTR突变.

主要方法:

开发含有人工核酸的反感性寡核酸 (ASOs),旨在针对RFFL.
在CF患者的初级人类支气管上皮细胞 (CF-HBE) 中测试优化的RFFL向ASO.
评估ASO对ΔF508-CFTR和CFTR突变体的功能性血表达和对调节器的反应的影响.

主要成果:

一个优化的RFFL向ASO增加了CF-HBE细胞中的功能 ΔF508-CFTR 血表达.
ASO对与罕见的CF形式相关的CFTR突变的ETI效应进行了强化,包括那些对调节器反应不佳的CF形式.
在某些情况下,ASO单独恢复了CFTR水平,相当于ETI治疗.

结论:

针对RFFL的ASO代表了一类新的CFTR稳定剂.
这种基于核酸的策略在治疗由常见和罕见的CFTR突变引起的囊性纤维化方面表现有前途.
ASO提供了一种潜在的治疗方法,以克服当前CFTR调节器疗法的局限性.

关键词:

在ASO的基础上,ASO是ASO.在CF中,CF是CF.在CFTR中,CFTR是最重要的.MT:寡核酸:治疗方法和应用.在RFFL中,RFFL是指RFFL.这是一种反意义的寡核酸.囊性纤维化症是什么囊性纤维化转膜导电性调节器无处不在的合酶

更多相关视频

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Published on: April 22, 2022

相关概念视频

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...